煙草在線據(jù)國際煙草雜志報(bào)道編譯　　奧馳亞集團(tuán)說，紐約上訴法院駁回了一項(xiàng)代表煙民提出的可能具有開創(chuàng)性的訴訟案。煙民們在訴訟中要求奧馳亞集團(tuán)為肺癌的早期檢驗(yàn)測試支付費(fèi)用。

　　奧馳亞在一份聲明中說，這宗訴訟要求法院命令擁有菲莫美國公司的奧馳亞集團(tuán)為長期吸煙的人及前煙民的CT檢測支付費(fèi)用。

　　紐約上訴法院在自己的意見書中維持了一家聯(lián)邦法院在2011年作出的駁回訴訟請求的裁決。紐約上訴法院說：“這個請求缺乏證據(jù)表明當(dāng)前人身遭到了傷害或給財(cái)產(chǎn)被造成了損失，允許提出這樣的訴訟請求就會大大偏離我們的侵權(quán)法院審判規(guī)程。”

Altria wins smokers' health screening suit

　　The New York Court of Appeals rejected a potentially ground breaking suit filed on behalf of smokers who asked Altria Group to pay for early detection tests for lung cancer, the cigarette maker said.

　　The suit asked the court to make Altria, which owns Philip Morris USA, to pay for computed tomography (CT) testing for long term smokers and former smokers, Altria said in a statement.

　　In its opinion, the appeals court upheld a 2011 dismissal of the claim by a federal district court. "Allowance of such a claim, absent any evidence of present physical injury or damage to property, would constitute a significant deviation from our tort jurisprudence", the court said.